Datasea Reports Fiscal Year 2026 Results with Gross Profit Up 70.1% and Gross Margin Increased to 10.2% Despite Lower Revenue

Positive operating cash flow and narrower losses accompanied lower revenue, while Nasdaq minimum bid price compliance remains unresolved.

Rhea-AI Summary

Datasea (Nasdaq: DTSS) reported fiscal 2026 gross profit growth of 70.1%, despite lower revenue for the year ended June 30, 2026. Revenue fell 43.17% to approximately $40.70 million from approximately $71.62 million in fiscal 2025. Gross profit reached approximately $4.16 million, and gross margin rose to 10.21% from 3.41%. Datasea attributed the revenue decline primarily to its deliberate reduction of lower-margin digital-service activities.

Operating loss narrowed to approximately $2.30 million, while net loss attributable to the company narrowed approximately 57.0% to approximately $2.19 million. Operating cash flow turned positive at approximately $1.98 million. Research and development spending increased approximately 180.3% to $2.57 million. Nasdaq granted an additional 180-calendar-day compliance period, until March 22, 2027, to regain compliance with its minimum bid price requirement.

10 points · 0 major

PositiveiHow this balance works

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

How the balance worksHow Sentiment works

0 major · 3 points

Hollow bars mark forward-looking points. How the balance works

Positive

• Moderate pointGross profit increased 70.09% to approximately $4.16 million from approximately $2.44 million in fiscal 2025.
• Moderate pointGross margin rose to 10.21% from 3.41% in fiscal 2025, improving approximately 6.8 percentage points.
• Moderate pointOperating cash flow turned positive at approximately $1.98 million versus approximately $2.37 million used in fiscal 2025.
• Moderate pointNet loss attributable to Datasea narrowed approximately 57.0% to approximately $2.19 million from approximately $5.09 million in fiscal 2025.
• Moderate pointOperating loss narrowed approximately 55.3% to approximately $2.30 million from approximately $5.15 million in fiscal 2025.

5 minor points

• Minor pointCost of revenues decreased approximately 47.2% year-over-year, faster than revenue's 43.17% decline.
• Minor pointSelling expenses declined approximately 38.5% in fiscal 2026 versus fiscal 2025.
• Minor pointGeneral and administrative expenses declined approximately 43.1% in fiscal 2026 versus fiscal 2025.
• Minor point. Forward-looking: it has not happened yet and may not happen.Acoustic intelligence plans include continued development, regulatory advancement and commercialization of healthcare and medical applications, including NeuroVibe.
• Minor point. Forward-looking: it has not happened yet and may not happen.AI solutions plans include continued shifting toward higher-value customized digital solutions and AI-agent services.

Negative

• Moderate pointRevenue fell 43.17% to approximately $40.70 million from approximately $71.62 million in fiscal 2025.
• Moderate pointResearch and development expenses increased approximately 180.3% to $2.57 million from approximately $0.91 million in fiscal 2025.
• Moderate pointNasdaq minimum bid price compliance remains pending, with an additional 180-calendar-day period ending March 22, 2027.

Argus 15 min delay 2 alerts

-4.05% vs previous close $0.81 last price 6.2x rel. volume Open Argus

Details

Market move: DTSS -4.05% vs previous close. Fiscal 2026 earnings report

$0.80 – $0.87 Day Range

$11.61M Market Cap

On Oct 5, the day this news came out, the latest delayed price for DTSS is 4.05% below the previous close. Our momentum scanner has recorded 2 alerts for this stock so far that day. The latest delayed price is $0.81. Relative volume is exceptionally heavy at 6.2x the average.

Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.

Key Figures

Revenue: $40.70 million, down 43.17% Gross profit: $4.16 million, up 70.09% Gross margin: 10.21%, up from 3.41% +5 more

Revenue

$40.70 million, down 43.17%

Fiscal 2026 vs. fiscal 2025

Gross profit

$4.16 million, up 70.09%

Fiscal 2026 vs. fiscal 2025

Gross margin

10.21%, up from 3.41%

Fiscal 2026 vs. fiscal 2025

Operating loss

$2.30 million, narrowed 55.3%

Fiscal 2026 vs. fiscal 2025

Net loss

$2.19 million, narrowed 57.0%

Fiscal 2026 vs. fiscal 2025

Operating cash flow

$1.98 million provided

Fiscal 2026; compared with $2.37 million used in fiscal 2025

Research and development expenses

$2.57 million, up 180.3%

Fiscal 2026 vs. fiscal 2025

Nasdaq compliance period

Additional 180 calendar days, through March 22, 2027

Time to regain compliance with the minimum bid price requirement

Previous Earnings Reports

1 past event · Latest: Nov 13

Same Type 1 event

1. Nov 13

   Q1 earnings

   24h Move

   -4.0%

   Gross profit and margin rose despite lower revenue as company shifted toward higher-margin services.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

form 20-f, biofeedback, brain-computer-interface

3 terms

form 20-f regulatory

"Additional details will be available in the Company's Annual Report on Form 20-F filed"

Form 20-F is the standardized annual disclosure that non-U.S. companies must file with the U.S. securities regulator when their shares are traded in the U.S.; it contains audited financial statements, a plain-language description of the business, management discussion, governance details and key risk factors. It matters to investors because it provides a consistent, comparable company “report card” and rulebook, helping buyers assess financial health, governance and risks before investing.

biofeedback medical

"acoustic intelligence, NeuroVibe, biofeedback and brain-computer-interface-related technologies"

Biofeedback is a therapy and set of devices that measures bodily signals—such as heart rate, muscle tension, or skin temperature—and displays them in real time like a dashboard so a person can learn to influence those functions. For investors, biofeedback matters because it sits at the crossroads of medical devices and digital health; its commercial potential depends on clinical evidence, regulatory clearance, insurance reimbursement, and the ability to sell devices, apps or services that reduce symptoms or cut healthcare costs.

brain-computer-interface technical

"biofeedback and brain-computer-interface-related technologies"

A brain-computer interface (BCI) is a system that reads and/or writes neural activity to enable direct communication between the brain and an external device. Typical BCIs combine sensors that record brain signals (or electrodes that stimulate neural tissue), electronics and software that filter and decode those signals, and an output device or controller that performs actions (for example moving a cursor, controlling a prosthetic limb, or delivering stimulation). BCIs vary by how they access the brain (noninvasive methods like EEG, minimally invasive sensors, or fully implanted electrodes) and by purpose (clinical therapy, assistive control, research, or consumer applications); the term describes the function of translating neural activity, not any particular level of invasiveness or specific use.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Net Loss Narrowed 57.0% and Operating Cash Flow Turned Positive; Company Also Received an Additional 180-Day Nasdaq Compliance Period

BEIJING, Oct. 5, 2026 /PRNewswire/ -- Datasea Intelligent Technology Ltd. (Nasdaq: DTSS) ("Datasea" or the "Company"), a technology company focused on acoustic intelligence and AI-powered multimodal and agent-based digital solutions, today announced its financial results for the fiscal year ended June 30, 2026. Additional details will be available in the Company's Annual Report on Form 20-F filed with the U.S. Securities and Exchange Commission.

Fiscal Year 2026 Financial Highlights

• Revenue: Approximately $40.70 million, compared with approximately $71.62 million in fiscal 2025, representing a decrease of 43.17%. The decline primarily reflected the Company's deliberate reduction of certain standardized, lower-margin AI multimodal, traffic-related and other digital-service activities as part of an active business-mix optimization strategy.
  
  
• Gross Profit: Approximately $4.16 million, compared with approximately $2.44 million in fiscal 2025, representing an increase of 70.09%, despite the decline in overall revenue.
  
  
• Gross Margin: Increased to 10.21% from 3.41% in fiscal 2025, an improvement of approximately 6.8 percentage points, primarily reflecting a reduced contribution from lower-margin standardized services and a greater relative contribution from customized solutions, acoustic-related products and services, and other activities.
  
  
• Cost of Revenues: Decreased approximately 47.2% year-over-year, at a rate greater than the 43.17% decrease in revenue, contributing to the significant improvement in gross profit and gross margin.
  
  
• Operating Expenses: Decreased approximately 15.0% to $6.46 million from approximately $7.60 million in fiscal 2025. Selling expenses declined approximately 38.5%, while general and administrative expenses declined approximately 43.1%.
  
  
• Research and Development: Increased approximately 180.3% to $2.57 million from approximately $0.91 million in fiscal 2025, reflecting continued investment in acoustic intelligence, NeuroVibe, biofeedback and brain-computer-interface-related technologies, acoustic signal enhancement, product engineering, AI multimodal perception and AI-agent technologies.
  
  
• Operating Loss: Narrowed to approximately $2.30 million from approximately $5.15 million in fiscal 2025, representing an improvement of approximately 55.3%.
  
  
• Net Loss Attributable to the Company: Narrowed to approximately $2.19 million from approximately $5.09 million in fiscal 2025, representing an improvement of approximately 57.0%.
  
  
• Operating Cash Flow: Net cash provided by operating activities was approximately $1.98 million, compared with net cash used in operating activities of approximately $2.37 million in fiscal 2025, representing a year-over-year improvement of approximately $4.35 million.

Management Commentary

Ms. Zhixin Liu, Chief Executive Officer of Datasea, commented:

"Fiscal 2026 was an important year in the evolution of Datasea's business model. Our reported revenue declined during the year. However, we believe revenue alone does not fully reflect the progress made in the underlying quality of our business. Cost of revenues declined faster than revenue, gross profit increased approximately 70%, and gross margin improved from 3.41% to 10.21%. These results reflect the financial impact of our efforts to improve our business mix and focus more closely on profitability and sustainable value creation."

"We also continued to improve operating efficiency. Selling and general and administrative expenses declined substantially, while we simultaneously increased research and development spending by approximately 180%. This reflects an important shift in how we allocate capital and operating resources — reducing lower-efficiency expenditures while continuing to invest aggressively in technologies and products that we believe can support Datasea's long-term growth."

"Importantly, these changes translated into a meaningful improvement in our bottom line. Operating loss narrowed by approximately 55%, net loss narrowed by approximately 57%, and operating cash flow turned positive for the fiscal year. While we have not yet reached profitability, we believe the significant narrowing of losses, together with higher gross margins and improved operating cash flow, represents meaningful progress toward a more balanced and sustainable earnings model."

The Company also recently received an additional 180-calendar-day compliance period from Nasdaq to regain compliance with the minimum bid price requirement until March 22, 2027. The additional compliance period provides the Company with further time to regain compliance in accordance with Nasdaq Listing Rule 5550(a)(2).

Investment in Technology and Future Growth

Rather than broadly reducing investment in response to lower revenue, Datasea continued to increase resources allocated to core technology development.

Research and development expenses increased to approximately $2.57 million in fiscal 2026, compared with approximately $0.91 million in fiscal 2025.

The Company's R&D activities during the year focused principally on acoustic intelligence, NeuroVibe and related biofeedback and brain-computer-interface technologies, acoustic signal enhancement, product engineering, AI multimodal perception, and AI-agent technologies and platform capabilities.

Datasea believes this resource allocation supports its longer-term strategy of transitioning from volume-driven digital services toward a portfolio with greater technology differentiation, stronger product capabilities and improved value-added potential.

Business Outlook

Looking ahead, Datasea intends to continue pursuing disciplined growth across its two principal technology platforms:

• Acoustic Intelligence: Continue product development, engineering, regulatory advancement and commercialization of acoustic healthcare and acoustic medical applications, including the NeuroVibe platform, while expanding the potential application of the Company's acoustic technologies across additional healthcare and industry scenarios.
  
  
• AI Multimodal and AI-Agent Solutions: Continue shifting toward higher-value customized digital solutions and AI-agent services designed to support enterprise customer operations, marketing execution, customer interaction, data analysis and other recurring business processes.

The Company believes fiscal 2026 represents an important stage in its transition toward a more technology-driven, higher-margin and operationally efficient business model. The pace and ultimate success of this transition will depend on customer adoption, commercialization progress, operating costs, market conditions and the Company's ability to convert its developing technologies and products into sustainable revenue and cash flow.

About Datasea Intelligent Technology Ltd.

Datasea Intelligent Technology Ltd. (Nasdaq: DTSS) is a technology company focused on acoustic intelligence and AI-powered multimodal and agent-based digital solutions.

The Company is developing and commercializing acoustic technologies across healthcare, medical and other application scenarios while continuing to advance AI multimodal technologies and AI-agent solutions designed to support enterprise digital operations and customer-service applications.

Through continued investment in technology development, product engineering and commercialization, Datasea seeks to build scalable technology platforms and higher-value products and services for customers in China, the United States and other markets.

For additional information, please visit www.dataseainc.com.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements involving risks and uncertainties, including but not limited to statements regarding the commercialization progress of the Company's products in target markets, compliance with regulatory obligations, market validation results, product iteration plans, channel development, application expansion and future business prospects. Actual results may differ materially from those expressed or implied by these forward-looking statements. Investors should not place undue reliance on these statements. Further information regarding risks and uncertainties is included in the Company's filings with the U.S. Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statement except as required by applicable law.

Investor and Media Contact:  

Datasea Investor Relations
Email:  investorrelations@shuhaixinxi.com 
            sunhezhi@shuhaixinxi.com 

Precept Investor Relations LLC
David Rudnick
+1 646-694-8538
david.rudnick@preceptir.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/datasea-reports-fiscal-year-2026-results-with-gross-profit-up-70-1-and-gross-margin-increased-to-10-2-despite-lower-revenue-302898492.html

SOURCE Datasea Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How did Datasea DTSS revenue and gross profit change in fiscal 2026?

Datasea's revenue decreased 43.17% to approximately $40.70 million, while gross profit increased 70.09% to approximately $4.16 million. Fiscal 2025 revenue was approximately $71.62 million and gross profit was approximately $2.44 million.

What is Datasea DTSS's Nasdaq minimum bid price compliance deadline?

Datasea has until March 22, 2027 to regain compliance with Nasdaq's minimum bid price requirement. Nasdaq granted an additional 180-calendar-day compliance period under Listing Rule 5550(a)(2).

What technologies did Datasea invest in during fiscal 2026?

Datasea's research and development focused on acoustic intelligence, NeuroVibe and related biofeedback and brain-computer-interface technologies, acoustic signal enhancement, product engineering, AI multimodal perception, and AI-agent technologies and platform capabilities.